Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Prothena Corp (PRTA)

Prothena Corp (PRTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Prothena (PRTA) Q1 Earnings and Revenues Miss Estimates Zacks - Fri May 5, 2023

Prothena (PRTA) reports a wider loss in the first quarter. The company makes considerable pipeline progress.

RHHBY : 30.0200 (-1.70%)
BMY : 44.70 (-8.51%)
NVO : 125.79 (-0.29%)
PRTA : 20.56 (unch)
Prothena (PRTA) Reports Q1 Loss, Lags Revenue Estimates Zacks - Thu May 4, 2023

Prothena (PRTA) delivered earnings and revenue surprises of -7.23% and 85.51%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

PRTA : 20.56 (unch)
AEZS : 1.9600 (-0.51%)
Prothena Reports First Quarter 2023 Financial Results and Business Highlights Business Wire - Thu May 4, 2023

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today reported financial...

PRTA : 20.56 (unch)
Prothena to Report First Quarter 2023 Financial Results on May 4 Business Wire - Thu Apr 27, 2023

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that...

PRTA : 20.56 (unch)
Prothena to Participate in 2023 Bank of America Healthcare Conference Business Wire - Mon Apr 24, 2023

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that...

PRTA : 20.56 (unch)
Walgreens and Prothena Partner to Increase Access and Enrollment in Alzheimer’s Disease Clinical Trial Business Wire - Thu Apr 13, 2023

Walgreens and Prothena today announced a collaboration to accelerate patient identification and recruitment for Prothena’s ongoing ASCENT-2 multiple ascending dose clinical trial evaluating the safety...

PRTA : 20.56 (unch)
WBA : 17.60 (-1.18%)
Prothena (PRTA) Gains 29% in One Year: Will the Momentum Continue? Zacks - Thu Apr 6, 2023

Prothena (PRTA) surges 29% in the past one year as investors are optimistic on its promising Alzheimer's Disease pipeline.

BIIB : 202.46 (+0.23%)
RHHBY : 30.0200 (-1.70%)
PRTA : 20.56 (unch)
Prothena Presents New Preclinical Data Supporting Best-in-Class Profile of PRX012, a Next-Generation Anti-Amyloid Beta Antibody, at AD/PD 2023 Business Wire - Fri Mar 31, 2023

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced new...

PRTA : 20.56 (unch)
Prothena to Participate in Stifel 2023 Virtual CNS Days Business Wire - Tue Mar 21, 2023

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that...

PRTA : 20.56 (unch)
Biotech Sector Working Fast to Combat Alzheimer’s Disease Cases That are Set to Explode FinancialNewsMedia - Wed Mar 15, 2023

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – March 15, 2023 – USA News Group  –  According to a 2022 study of more than 6 million patients 65 and older, the risk factor...

MRVL.VN : 0.135 (unch)
BIIB : 202.46 (+0.23%)
PRTA : 20.56 (unch)
ITCI : 72.13 (-1.35%)
RHHBY : 30.0200 (-1.70%)

Barchart Exclusives

This Dividend King Is Now One of BofA's Investment Best Ideas Barchart - Thu Apr 25, 6:30PM CDT
Discover why S&P Global, a seasoned Dividend King, has not only secured a spot on Bank of America's prestigious US 1 List, but also why analysts are bullish about its investment potential in the current economic climate. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot